The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| APPRECIATE HOLDINGS INC | CLASS A COM | 03832J106 | BBG00XWZGF21 | 1,748,373 | 3,067,321 | SH | SOLE | 3,067,321 | 0 | 0 | ||
| GOLDEN FALCON ACQUISITION CO | CL A | 38102H109 | BBG00YRRYSV3 | 5,065,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| LANZATECH GLOBAL INC | COM | 51655R101 | BBG00ZCX69R1 | 11,601,200 | 2,990,000 | SH | SOLE | 2,990,000 | 0 | 0 | ||
| LANZATECH GLOBAL INC | *W EXP 01/01/202 | 51655R119 | BBG00ZSKRK12 | 844,200 | 2,010,000 | SH | SOLE | 2,010,000 | 0 | 0 | ||
| OCEAN BIOMEDICAL INC | COM | 67644C104 | BBG011WXCRR6 | 10,082,920 | 1,518,512 | SH | SOLE | 1,518,512 | 0 | 0 | ||
| RUBICON TECHNOLOGIES INC | CL A COM | 78112J109 | BBG011Y6M108 | 1,076,724 | 1,640,848 | SH | SOLE | 1,640,848 | 0 | 0 | ||
| SATIXFY COMMUNICATIONS LTD | ORD SHS | M82363124 | BBG01B6WZ632 | 1,917,795 | 2,836,975 | SH | SOLE | 6,150,000 | 0 | 0 | ||
| SEASTAR MEDICAL HOLDING CORP | COMMON STOCK | 81256L104 | BBG00YVJVRK3 | 1,159,524 | 623,400 | SH | SOLE | 623,400 | 0 | 0 | ||
| SHF HOLDINGS INC | CLASS A COM | 824430102 | BBG011CHSYC7 | 495,314 | 971,204 | SH | SOLE | 971,204 | 0 | 0 | ||